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The rate of identified isolated subsegmental pulmonary embolism (ssPE)
has doubled with advances in computed tomography pulmonary angiogra-
phy (CTPA) technology, but its clinical relevance is debated. The YEARS
diagnostic algorithm was shown to safely reduce the number of required
CTPAs in the diagnostic management of PE. We hypothesized that the
higher threshold for performing CTPA in YEARS was associated with a
lower prevalence of ssPE compared to the conventional diagnostic algo-
rithm. We compared 2291 consecutive patients with suspected PE managed
according to YEARS to 3306 consecutive control patients managed accord-
ing to the Wells score for the prevalence of isolated ssPE. In the YEARS
cohort, 52% were managed without CTPA, 12% had pulmonary embolism
(PE) of which 10% were isolated ssPE, and the 3-month diagnostic failure
rate was 035%. In the control cohort, 32% were managed without CTPA,
20% had PE of which 16% were isolated ssPE, and the 3-month failure rate
was 073%. The isolated ssPE prevalence was significantly lower in YEARS
(absolute difference 62% (95% confidence interval [CI] 14–10), Odds
Ratio 058 (95% CI 037–090). In conclusion, YEARS is associated with a
lower prevalence of isolated ssPE, due to reduction in CTPAs by the higher
D-dimer threshold. This was however not associated with a higher risk of
recurrent VTE during follow-up.
Keywords: pulmonary embolism, D-dimer, diagnosis, computed tomography,
subsegmental pulmonary embolism.
Since the introduction of multi-detector computed tomogra-
phy pulmonary angiography (CTPA), the sensitivity of this
diagnostic technique for visualizing smaller pulmonary
embolisms (PE) has noticeably advanced. These advances
have led to a more frequent detection of filling defects in
subsegmental pulmonary arteries – with diameters as small
as 2–3 mm – by multi-detector computed tomography
(MDCT) compared to single detector computed tomography
(SDCT; Fig 1) (Carrier et al, 2010; Klok & Huisman, 2017).
The rate of isolated subsegmental PE (ssPE) diagnosis has
doubled since the introduction of the MDCT, from 47%
(95% confidence interval [CI]: 25–76%) to 94% (95% CI:
55–142%) (Carrier et al, 2010; Konstantinides et al, 2016).
Despite this increase in isolated ssPE diagnoses, the risk of
fatal PE has remained unchanged, suggesting that not all iso-
lated ssPE may be clinically relevant (Le Gal et al, 2006; Car-
rier et al, 2010).
Recently, a number of studies have been designed to opti-
mize diagnostic strategies for suspected acute PE. Ultimately,
they aimed to lower the number of necessary CTPAs, thereby
reducing the number of patients exposed to ionizing radia-
tion and simplify diagnostic management in busy clinical
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practices (den Exter et al, 2013; van der Hulle et al, 2017).
The YEARS algorithm involves a D-dimer test that is com-
bined with three clinical variables, i.e. clinical signs of deep
venous thrombosis, haemoptysis and “PE most likely diagno-
sis”. In the absence of YEARS items, the D-dimer threshold
to rule out PE without CTPA is 1000 ng/ml and in patients
with one or more YEARS items the D-dimer threshold
remains 500 ng/ml. All patients with D-dimer levels higher
than these D-dimer thresholds require a CTPA examination
(Fig 2). We have shown that this algorithm is safe with a
failure rate of the overall algorithm of 061% (95% CI 036–
096) and a resultant 14% reduction in CTPA examinations
compared to the standard algorithm with the conventional
Wells rule and fixed D-dimer threshold of <500 ng/ml (van
der Hulle et al, 2017).
We hypothesized that this reduction in CTPA examina-
tions has led to a decreased rate of smaller more distal
emboli diagnosis without a higher incidence of recurrent
VTE during the 3-month follow-up. To test this hypothesis,
we compared the percentage of isolated ssPE diagnoses in
patients managed according to the YEARS algorithm to
patients managed according to the conventional algorithm




This was a post-hoc analysis with the combined data of two
prospective outcome studies, i.e. the YEARS study and the
Christopher study, in which consecutive, haemodynamically
stable in- and out-patients with clinically suspected PE had
Fig 1. Isolated subsegmental pulmonary embolism (arrow) on com-
puted tomography pulmonary angiography.
Suspected acute pulmonary embolism
D-dimer test and scoring of YEARS-items:
- Clinical signs of deep venous thrombosis?
- Hemoptysis?
- PE most likely diagnosis?
0 YEARS items ≥1 YEARS items
n = 2291









n = 981 n = 302 n = 218 n = 790
PE excluded Order CTPA PE excluded Order CTPA
0 PE34 CTPAs posive 
for PE of which
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for PE of which
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Fig 2. Years algorithm and study flowchart. CTPA, computed tomography pulmonary angiography; PE, pulmonary embolism; ssPE, subsegmental
pulmonary embolism.
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been included in the same Dutch Hospitals (van Belle et al,
2006; van der Hulle et al, 2017). We used the Christopher
population as the proxy for current clinical practice.
The YEARS study evaluated the safety and efficiency of
the YEARS algorithm in 3465 consecutive in- and out-
patients aged 18 years or older from October 2013 to July
2015 (Fig 2) (van der Hulle et al, 2017). Exclusion criteria
were treatment with therapeutic doses of anticoagulants initi-
ated ≥24 h prior to eligibility assessment, pregnancy, allergy
to intravenous contrast agents, life expectancy less than
3 months or geographic inaccessibility precluding follow-up.
Patients were managed according to the YEARS algorithm
(Fig 2). D-dimer concentrations were measured with auto-
mated well validated high-sensitive quantitative D-dimer
assays (Tinaquant, Roche Diagnostica, Mannheim, Germany;
Innovance, Siemens, Malburg, Germany and STA-LIA Diag-
nostica Stage, Asnieres, France) according to local practice.
Patients in whom PE was ruled out were left untreated and
anticoagulant treatment was started in patients with a con-
firmed PE diagnosis. Results were reported using an inten-
tion-to-diagnose approach. All patients were followed for a
3-month period for the occurrence of (fatal) recurrent
venous thromboembolism (VTE) (van der Hulle et al, 2017).
The current study was restricted to 2291 patients from four
study sites participating in the YEARS study, i.e. Leiden
University Medical Centre (Leiden), Academic Medical Cen-
tre (Amsterdam), Flevo Hospital (Almere) and Haga Teach-
ing Hospital (The Hague). We restricted our analysis to
these four hospitals because they comprised the majority of
included patients and all original CTPA examinations were
readily available for analysis.
The Christopher study included 3306 normotensive con-
secutive in- and out-patients with clinically suspected PE
(van Belle et al, 2006). Patients were included from Novem-
ber 2002 to September 2004. The probability of PE was clas-
sified as “unlikely” with a Wells clinical decision rule score
of 4 points or less, and “likely” with a Wells score of more
than 4 points. In all patients with an “unlikely” score, a D-
dimer was measured and PE was considered to be ruled out
if the D-dimer was <500 ng/ml. Anticoagulant treatment was
withheld in these latter patients. Patients with a D-dimer
≥500 ng/ml and all patients with a “likely” score were
directly referred for CTPA. Exclusion criteria were treatment
with therapeutic doses of unfractionated or low-molecular-
weight heparin, life expectancy <3 months, allergy to intra-
venous contrast agents, renal impairment (creatinine clear-
ance <30 ml/min) or haemodynamic instability. All patients
were followed for 3 months for the occurrence of symp-
tomatic (fatal/recurrent) VTE (van Belle et al, 2006).
Radiological evaluation
An MDCT was performed in all patients from the YEARS
cohort with an indication for CTPA (van der Hulle et al,
2017). In the Christopher study, CTPA was performed using
either SDCT or MDCT (van Belle et al, 2006). In both stud-
ies, the pulmonary arteries were evaluated up to at least the
subsegmental vessels by the attending radiologist. PE was
diagnosed if a filling defect was detected or if a vessel was
totally occluded by low-attenuation material on at least 2
adjacent slices.
For all patients in this analysis, we used the previously
reported frequencies of isolated ssPE by the local attending
radiologist, who was either a certified radiologist, or a resi-
dent under supervision of certified radiologist. The definition
of isolated ssPE was dependent on this local attending
radiologist.
To assess the accuracy of the clinical ssPE diagnosis, all
computed tomography (CT) scans from the YEARS study
were reassessed by an independent reader who was blinded
to the original CT report by the local attending radiologist,
as well as to patient characteristics, clinical presentation,
treatment decisions and outcome. For the patients from the
Christopher study, we used previously reported frequencies
of isolated ssPE (van Belle et al, 2006). These CT scans were
not available for re-evaluation.
Endpoints
This analysis was performed to determine the absolute differ-
ence in isolated ssPE prevalence between the YEARS cohort
and the Christopher cohort. Other endpoints were the num-
ber of CTPA examinations required to safely confirm or rule
out PE between both cohorts and the difference in failure
rate (occurrence of VTE during 3-month follow-up).
A second analysis was performed in patients from both
cohorts to evaluate if subsegmental thrombus location was
associated with a lower D-dimer level than more proximal
PE. Also, we determined if isolated ssPE diagnoses would
have been missed if YEARS would have been applied in the
Christopher cohort.
Statistical analysis
To compare the prevalence of isolated ssPE, the required
number of CTPA examinations and the failure rate in the
YEARS study versus the Christopher study, absolute differ-
ence and the Odds Ratios (OR) with exact 95% CIs were cal-
culated. To evaluate the association between D-dimer level
and location of the thrombus, we compared the median D-
dimer level in the patients with isolated ssPE versus more
proximal PE from both patient cohorts. The Mann-Whitney-
U test was performed to determine the level of significance
between both groups. To evaluate if ssPE diagnoses would
have been missed when applying YEARS in the Christopher
cohort, the YEARS score was calculated post-hoc for all
patients of the Christopher cohort. For measurement of
inter-observer agreement between the independent reader
and the local attending radiologist for isolated ssPE, Cohen’s
kappa was calculated in two different cohorts: (i) for the
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adjudication of isolated ssPE in the complete cohort, (ii) for
adjudication of isolated ssPE within the group of patients
with confirmed and treated PE. The kappa value for agree-
ment was interpreted as follows: poor (<020), fair (021–
040), moderate (041–060), good (061–080) or very good
(081–100) (Cohen, 1968). P-values <005 were considered
statistically significant. All analysis were performed using
SPSS version 23.0, Chicago, USA.
Results
YEARS cohort
The median age of the 2291 patients in the YEARS cohort
was 53 years (interquartile range (IQR) 40–67), 39% of
these patients were men and 88% were outpatients (van
der Hulle et al, 2017). The median age of patients with
confirmed isolated ssPE was 66 years (IQR 48–77), 36% of
these patients were men and 89% were outpatients
(Table I).
According to the intention-to-diagnose approach, 1092
out of 2291 patients (48%) underwent CTPA and the diag-
nosis of PE was confirmed in 278 patients (12%). In 28
patients (10% of all PE diagnosis) PE was limited to only the
subsegmental arteries, leaving 250 patients with PE localized
in at least one segmental or central branch of the pulmonary
artery (Table II). The Cohen’s kappa statistic comparing the
assessment of the local attending radiologist and the inde-
pendent blinded reviewer for isolated ssPE within the com-
plete patient cohort (n = 2291) was 080 and for ssPE within
the PE cohort (n = 278) it was 078, indicative of ‘good’
agreement. Of all patients with isolated ssPE, 22 patients had
1–3 YEARS items and a D-dimer above 500 ng/ml and 6
patients had 0 YEARS items and a D-dimer above 1000 ng/
ml (Fig 2).
Of the 1924 patients in whom PE was ruled out at base-
line, who remained untreated and completed the follow-up
period of 3 months, 8 patients were diagnosed with recurrent
VTE (2 fatal PE) during follow-up for a failure rate of 042%
(95% CI 021–082).
Table I. Baseline characteristics.
YEARS cohort (van der Hulle et al,
2017)










Age, years; median (IQR) or mean (SD) 53 (40–67) 66 (48–77) 53 (184) 57 (170)
Male sex, n (%) 891 (389) 10 (357) 1409 (426) 60 (545)
Outpatients, n (%) 2023 (883) 25 (893) 2701 (817) 81 (736)
Duration of complaint, days, median (IQR) 3 (1–9) 3 (10–185) 2 (1–5) 1 (0–4)
VTE risk factors
Immobilization/surgery, n (%) 255 (111) 6 (214) 610 (185) 38 (345)
Previous VTE, n (%) 234 (102) 4 (143) 480 (145) 15 (136)
Active malignancy, n (%) 212 (93) 3 (107) 476 (144) 21 (191)
Oestrogen use, women, n (%) 193 (85) 1 (36) 438 (231) 16 (320)
Comorbidities
Heart failure, n (%) 92 (40) 1 (36) 243 (74) 9 (82)
COPD, n (%) 270 (118) 3 (107) 341 (103) 11 (100)
COPD, chronic obstructive pulmonary disease; IQR, interquartile range; SD, standard deviation; ssPE, subsegmental pulmonary embolism; VTE,
venous thromboembolism.










PE prevalence, n (%) 278 (12) 676 (20) 83% (64–10)
Isolated ssPE prevalence, n (%) 28 (10) 110 (16) 62% (14–10)
CTPA indicated, n (%) 1092 (48) 2249 (68) 204% (18–23)
3-month VTE rate, % (95% CI) 042 (021–082) 073 (049–11) 032 (015–074)
CI, confidence interval; CTPA, computed tomography pulmonary angiography; PE, pulmonary embolism; ssPE, subsegmental pulmonary embo-
lism; VTE, venous thromboembolism.
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Christopher cohort
A total of 3306 consecutive patients were included in the
Christopher study with a mean age of 53 years (standard
deviation 184), 43% were male patients and 82% were out-
patients (Table I) (van Belle et al, 2006). A total of 1057
patients (32%) were managed without CTPA. PE was diag-
nosed in 676 patients for a PE-prevalence of 20% (Table II).
MDCT was performed in 1939 patients and SDCT in 260
patients. Among all patients with confirmed PE, 110 (16%)
patients were diagnosed with isolated ssPE. Of all patients
who remained untreated, 23 were diagnosed with recurrent
VTE (7 fatal PE) during the 3-month follow-up period for a
failure rate of 073% (95% CI 049–11).
Difference between both cohorts
The prevalence of isolated ssPE was significantly lower in the
YEARS cohort, with an absolute difference of isolated ssPE
prevalence in patients with confirmed PE of 62% (95% CI
14–10) for an OR of 058 (95% CI 037–090). The absolute
difference of isolated ssPE prevalence between both cohorts
among all included patients was 21% (95% CI 13–29) for
an OR of 036 (95% CI 024–055). CTPA was indicated in
48% of the YEARS cohort versus 68% in the Christopher
cohort for an absolute difference of 20% (95% CI 18–23) in
favour of the YEARS algorithm. The 032% difference
in the 3-month recurrent VTE rate in untreated patients
between the cohorts was not statistically significant (95% CI
Table II).
Secondary endpoints
D-dimer levels were not measured in 185 patients with con-
firmed PE from the Christopher cohort because they had a
likely probability of PE, i.e. a Wells score of more than 4
points, and were referred for CTPA without D-dimer mea-
surement. In all other patients with available D-dimer test
results from both studies, the median D-dimer level of
patients with isolated ssPE was 1571 ng/ml (IQR 1010–3025)
compared to 3205 ng/ml in patients with more proximal PE
(IQR 1666–5000, P<001; Fig 3). Of all 110 patients diag-
nosed with isolated ssPE in the Christopher cohort, 11
patients (10% of ssPE diagnosis and 2% of all PE diagnoses)
would have remained undetected if the YEARS algorithm
had been applied: 7 patients with 0 YEARS items and a D-
dimer below 1000 ng/ml and 4 patients with 1–3 YEARS
items and a D-dimer below 500 ng/ml.
Discussion
This analysis demonstrates a lower prevalence of isolated
ssPE in patients managed according to the YEARS algorithm
compared with a traditional algorithm, without compromis-
ing the safety of the diagnostic work-up. This difference was
the consequence of a lower sensitivity of YEARS for smaller
more distal emboli due to the higher threshold for perform-
ing CTPA scans because of the pre-test probability dependent
D-dimer cut-off. This is explained in two ways.
First, we confirmed the previously described association
between D-dimer level and location of PE, where isolated
ssPE is associated with a lower median D-dimer level than
more proximal PE (De Monye et al, 2002; Klok et al, 2008;
Jeebun et al, 2010). De Monye et al (2002) demonstrated the
correlation between D-dimer level and thrombus location in
a prospective cohort study in patients with clinically sus-
pected PE: D-dimer levels were clearly lower in the group of
patients with isolated ssPE (De Monye et al, 2002). Another
study confirmed this observation (Jeebun et al, 2010). Sec-
ond, we showed that 10% of all isolated ssPE diagnoses
would have remained undetected if the YEARS algorithm
would have been used instead of the standard diagnostic
algorithm in the Christopher study. This notable reduction
was not associated with a higher rate of symptomatic VTE
events among the untreated patients of the YEARS study
with an initial negative ruling by the diagnostic algorithm
during the 3-month follow-up period. These findings support
the hypothesis that some isolated ssPE cases may safely
remain untreated, although our results should be regarded as
hypothesis-generating.
To date, there is limited, uncontrolled evidence in a little
over 50 patients with confirmed isolated ssPE without deep
venous thrombosis (DVT) who remained untreated and none
suffered recurrent PE during follow-up (Le Gal et al, 2006;
Donato et al, 2010). Based on these observations, interna-
tional guidelines suggest clinical surveillance over treatment
with anticoagulants in patients with isolated ssPE and no
proximal DVT in the legs who have a low risk for recurrent
VTE, i.e. patients who are not hospitalized or have reduced
mobility and those without active cancer (Class IIb, Grade

























Fig 3. D-dimer levels and location of pulmonary embolism (PE) in
the YEARS and Christopher studies.
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currently active outcome study is evaluating the safety of
withholding anticoagulant therapy in 300 patients without a
history of VTE or cancer who have confirmed isolated ssPE
without proximal DVT on bilateral lower extremity ultra-
sound (NCT01455818). Until the results of this study are
available, the decision whether to start anticoagulant treat-
ment in patients with isolated ssPE should be made on an
individual basis, taking into account the risk of recurrent PE
versus the risk of major bleeding with or without anticoagu-
lant treatment.
We found a good inter-observer agreement of isolated
ssPE diagnosis in the cohort of all PE-patients of 078. Prior
studies using the same comparison have suggested that the
inter-observer agreement of the presence of PE depends on
the location of the thrombus, with a fair to moderate inter
observer agreement for isolated ssPE versus high agreement
for more proximal PE. Miller et al (2015) demonstrated a
moderate inter-observer agreement for subsegmental pul-
monary artery defects of 053, especially in CTPA degraded
with technical artefacts, such as breathing motion artefact,
artefacts due to cardiac pulsation or beam-hardening from
adjacent high-density structures (Hutchinson et al, 2015;
Miller et al, 2015). Ghanima et al (2007) found a low inter-
observer agreement of 25%, with a kappa of 038 (95% CI
00–089). Although our data do not allow firm conclusions
on the reasons for the difference between the current and
prior studies, we hypothesize that the further advancements
in CT technology since 2002–2008 [inclusion period of the
studies reported by Ghanima et al (2007) and Miller et al
(2015)] and the very low number of technically inadequate
CT scans in the YEARS study may have contributed to the
good inter-observer agreement found in the current analysis.
Strengths of our study include the prospective data collec-
tion and comparison of two large cohorts of consecutive in-
and out-patients with suspected PE with similar inclusion
and exclusion criteria from the same Dutch hospitals. More-
over, we could clearly explain the cause of the observed
lower isolated ssPE prevalence among patients managed
according to YEARS, supporting the biological plausibility of
our conclusion.
The fact that only half of the study population of the
YEARS study was subjected to CTPA prevents accurate
assessment of the actual number of patients with ssPE that
were not detected and remained untreated. In contrast, it
remains unclear if patients with isolated ssPE from the
Christopher study who would not have been referred for
CTPA according to YEARS, would have had an uneventful
follow-up without treatment. Limitations of this post-hoc
analysis are that not all patients from the YEARS study were
included. We restricted our analysis to four of the participat-
ing centres, which included 66% of the total study patients
and in which all original CTPA examinations were readily
available for analysis. Second, the association between D-
dimer level and location of the thrombus was made with
data from both study cohorts and from all four hospitals that
included patients in the YEARS study. Bias could have been
introduced in the analysis of the association of D-dimer level
and PE localisation because different D-dimer assays were
used in the participating hospitals and within the hospitals
over time. Third, the PE prevalence in YEARS was lower
than in Christopher. Although this difference can be partly
explained by the lower prevalence of isolated ssPE, we cannot
rule out bias towards overestimation of the primary end-
point. Further, the two studies were performed in different
time periods (2002–2004 and 2013–2015), allowing for bias
due to for instance differences in CT technology. Indeed,
where only state-of-the-art MDCT machines were used in
the YEARS study, 260 patients from the Christopher cohort
were managed with SDCT. Even so, because MDCT allows
better visualization of segmental and subsegmental pul-
monary arteries, making it easier to detect smaller more dis-
tal emboli, the prevalence of isolated ssPE was still lower in
the YEARS cohort than in the Christopher cohort, support-
ing the validity of our findings.
In conclusion, we demonstrated a lower prevalence of
isolated ssPE in patients managed according to the YEARS
algorithm compared with the conventional diagnostic strat-
egy mainly used in daily clinical practice. This lower
prevalence of isolated ssPE is a consequence of the lower
sensitivity of YEARS for ssPE due to the higher D-dimer
threshold. Our study provides further indirect evidence
that some isolated ssPE may be left untreated in selected
patients, although definite proof will only be provided by
outcome studies in which patients with ssPE are left
untreated. Further, these findings support the relevance of
the YEARS, due to its easy applicability, the reduction in
number of required CTPAs, the low failure rate and -last
but not least- the associated lower prevalence of isolated
ssPE. This was, however, not associated with a higher risk
of recurrent VTE during follow-up, providing indirect evi-
dence that some ssPE may be left untreated in selected
patients, although our study was underpowered to detect
small differences.
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